Category: CovidienSyndicate content

Medtronic's Q4 sales surge 60% on Covidien buy, outlook narrowed

May 19, 2015 by Brad Perriello

Medtronic's fiscal 4th-quarter sales surge nearly 60% thanks to its buyout earlier this year of Covidien, prompting the medical device company to tighten its earning forecast.

Medtronic's Q4 sales surge 60% on Covidien buy, outlook raised

Whistleblowing ex-Covidien rep sues for wrongful termination

May 18, 2015 by Brad Perriello

A former sales rep for Covidien's vascular business in Southern California accuses the company of firing him for blowing the whistle on an alleged kickbacks scheme.

Whistleblowing ex-Covidien rep sues for wrongful termination

A former sales rep for Covidien's vascular business accused the company of wrongful termination after it fired him for blowing the whistle to the FBI on an alleged kickbacks scheme.

Spectranetics to boost Stellarex spend

April 24, 2015 by Brad Perriello

Spectranetics says it plans to boost its R&D spend on the Stellarex drug-eluting balloon it bought from Covidien.

Spectranetics to boost Stellarex spend

Spectranetics touts Stellarex drug-eluting balloon data

April 21, 2015 by Mark Hollmer

Spectranetics touts 2-year data from a study of the Stellarex drug-eluting balloon it bought from Covidien earlier this year.

Spectranetics touts Stellarex drug-eluting balloon data

PAD: Medtronic launches HawkOne directional atherectomy device

April 9, 2015 by Brad Perriello

Medtronic says it's launching a new directional atherectomy device called the HawkOne to treat peripheral artery disease.

PAD: Medtronic launches HawkOne directional atherectomy device

PAD: Medtronic touts 3-year EverFlex stent data

April 3, 2015 by Mark Hollmer

Medtronic touts positive 3-year results for the EverFlex self-expanding stent for treating peripheral artery disease it acquired when it bought Covidien for $50 billion.

PAD: Medtronic touts 3-year EverFlex stent data

BSX wins CE Mark, FDA nod for new S-ICD | Regulatory news for the week of March 23, 2015

March 24, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark, FDA nod for smaller 'leadless' ICD; FDA approves Biotronik's Eluna MRI-safe pacemaker; PAD: Medtronic wins expanded FDA nod for Protégé GPS stent; Australian PE shop acquires Simplify Medical

Boston Scientific wins CE Mark, FDA nod for smaller 'leadless' ICD

March 17, 2015 by Brad Perriello